BPG is committed to discovery and dissemination of knowledge
Articles in Press
12/22/2025 3:45:24 AM | Browse: 21 | Download: 0
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Post-chemotherapy C-reactive protein/albumin ratio predicts prognosis in stage II-III colorectal cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Fei-Fei Kong, Xuan Geng, Ru-Ming Liu, Wen-Tao Zhang, Bin Quan, Yong Zhong and You-Long Zhu |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| The Affiliated Hospital of Xuzhou Medical University |
2023ZL08 |
|
| Corresponding Author |
You-Long Zhu, MD, Department of Gastrointestinal Surgery, Xuzhou Central Hospital, No. 199 Jiefang South Road, Xuzhou 221000, Jiangsu Province, China. b2418273@zju.edu.cn |
| Key Words |
C-reactive protein/albumin ratio; Post-adjuvant chemotherapy; Prognostic scores; Neutrophil-to-lymphocyte ratio; Platelet-to-lymphocyte ratio; Systemic immune-inflammation index |
| Core Tip |
In this study, we evaluated inflammation-related prognostic markers in patients with colorectal cancer. The results indicated a strong connection between C-reactive protein/albumin ratio values and adverse prognoses. Moreover, the longitudinal changes of inflammation-related prognostic markers had a significant impact on the prognosis of these patients following adjuvant chemotherapy. Therefore, assessing hematological markers is instrumental in evaluating disease progression and prognosis in patients with colorectal cancer. |
| Citation |
Kong FF, Geng X, Liu RM, Zhang WT, Quan B, Zhong Y, Zhu YL. Post-chemotherapy C-reactive protein/albumin ratio predicts prognosis in stage II-III colorectal cancer. World J Gastrointest Surg 2025; In press |
 |
Received |
|
2025-09-16 09:37 |
 |
Peer-Review Started |
|
2025-09-16 09:37 |
 |
First Decision by Editorial Office Director |
|
2025-10-10 02:30 |
 |
Return for Revision |
|
2025-10-10 02:30 |
 |
Revised |
|
2025-11-04 09:15 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2025-12-22 02:40 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2025-12-22 03:45 |
 |
Articles in Press |
|
2025-12-22 03:45 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1948-9366 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345